GlaxoSmithKline PLC Director Declaration (8075G)
08 Noviembre 2018 - 6:43AM
UK Regulatory
TIDMGSK
RNS Number : 8075G
GlaxoSmithKline PLC
08 November 2018
GlaxoSmithKline plc
Director Declaration
In conformity with Listing Rule 9.6.14, GlaxoSmithKline plc (the
'Company') hereby notifies the market that Dr Jesse Goodman, a
Non-Executive Director of the Company, has been appointed as a
Director to the Board of Intellia Therapeutics, Inc. with effect
from 31 October 2018.
V A Whyte
Company Secretary
8 November 2018
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
RDNEAAFPELAPFFF
(END) Dow Jones Newswires
November 08, 2018 07:43 ET (12:43 GMT)
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Gsk (LSE:GSK)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024